Zobrazeno 1 - 8
of 8
pro vyhledávání: ''
Publikováno v:
Value in Health. 22:S66
Publikováno v:
Value in Health. 20:A616
Publikováno v:
Value in Health. 20:A550
Publikováno v:
Value in Health. 8(6):647-655
Objective A composite outcome measure in migraine treatment assessment is useful to clinical decision-makers and payers as it can provide a more accurate reflection of effectiveness and allows for more complete modeling of economic value. The objecti
Autor:
Nicholas, Wells, Jayasena, Hettiarachchi, Michael, Drummond, Mcom, DPhil, David, Carter, Tamiza, Parpia, Francis, Pang
Publikováno v:
Value in Health. 6:438-447
Objectives This article explores the application of cost-effectiveness analysis in a comparison of eletriptan and sumatriptan in the acute treatment of migraine. Methods The study employs data from a randomized, double-blind, placebo-controlled clini
Publikováno v:
Value in Health. 12(7)
Publikováno v:
Value in Health. 15(4):A143-A144
Publikováno v:
Value in Health, 16(7). ELSEVIER SCIENCE INC
Objectives: Management with vitamin K antagonists (VKAs) has been an effective and cost-effective strategy for stroke prevention in atrial fibrillation (AF) but is associated with shortcomings. Novel oral anticoagulants (NOACs) were developed with th